Antenatal influenza vaccination in urban Pune, India: clinician and community stakeholders' awareness, priorities, and practices.
Antenatal influenza vaccination
India
community vaccine recipients
vaccination stakeholders
vaccine acceptance
vaccine demand
vaccine priority
Journal
Human vaccines & immunotherapeutics
ISSN: 2164-554X
Titre abrégé: Hum Vaccin Immunother
Pays: United States
ID NLM: 101572652
Informations de publication
Date de publication:
03 04 2021
03 04 2021
Historique:
pubmed:
24
9
2020
medline:
6
7
2021
entrez:
23
9
2020
Statut:
ppublish
Résumé
The World Health Organization (WHO) recommends antenatal influenza vaccination (AIV) for pregnant women at any stage of pregnancy. This study assessed fundamental aspects of AIV acceptance and demand among key stakeholders in urban Pune, India. Semi-structured interviews for rapid ethnographic assessment of AIV-related awareness, priorities, and practices were used to study clinicians and their communities of practice. A qualitative survey was conducted among 16 private clinicians providing antenatal care (ANC) in slum and middle-class areas of Pune. Following the survey, clinicians were informed about authoritative AIV recommendations. A qualitative community survey was also conducted with 60 women aged 20-35 years and 30 spouses from the same slum and middle-class practice areas of the ANC providers. Subsequently, a second clinician survey was conducted to assess changes in clinicians' awareness, priority, and vaccination practice. After this interview, clinicians were informed of community survey findings. Most community respondents were unaware of AIV, in contrast with well-known and widely used antenatal tetanus vaccination. They expressed confidence in vaccines and trust in the clinicians. Clinicians' advice was reportedly the most important determinant of community vaccine acceptance. Clinicians were confident of the safety of AIV and they anticipated patients' acceptance if recommended. The second clinician interview showed increased awareness of AIV policy, but clinicians were more skeptical about the severity of maternal influenza in their practice. Our findings indicate community acceptance though not demand for AIV. We recommend five essential elements for vaccination program strategies to improve coverage with AIV and other ANC vaccines.
Identifiants
pubmed: 32966146
doi: 10.1080/21645515.2020.1806670
pmc: PMC8018408
doi:
Substances chimiques
Influenza Vaccines
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, P.H.S.
Langues
eng
Sous-ensembles de citation
IM
Pagination
1211-1222Subventions
Organisme : NCEZID CDC HHS
ID : U50 CK000431
Pays : United States
Références
PLoS Med. 2011 May;8(5):e1000441
pubmed: 21655318
Wkly Epidemiol Rec. 2012 Nov 23;87(47):461-76
pubmed: 23210147
Hum Vaccin Immunother. 2018 Jul 3;14(7):1591-1598
pubmed: 29494274
J Reprod Med. 2007 Sep;52(9):753-6
pubmed: 17939588
Hum Vaccin Immunother. 2014;10(10):2922-9
pubmed: 25483464
J Obstet Gynaecol Can. 2008 May;30(5):404-10
pubmed: 18505664
Int J Health Policy Manag. 2017 May 09;7(2):154-166
pubmed: 29524939
Aust N Z J Obstet Gynaecol. 2015 Apr;55(2):131-7
pubmed: 25557858
BMC Public Health. 2015 Dec 29;16:1308
pubmed: 26965449
Vaccine. 2019 Dec 10;37(52):7539-7546
pubmed: 31630937
Am J Prev Med. 2009 Sep;37(3):231-4
pubmed: 19596538
Hum Vaccin Immunother. 2015;11(10):2376-88
pubmed: 26110454
Am J Obstet Gynecol. 2012 Sep;207(3 Suppl):S9-16
pubmed: 22920065
J Korean Med Sci. 2016 Jul;31(7):1063-8
pubmed: 27366003
Int J Epidemiol. 1989;18(4 Suppl 2):S33-7
pubmed: 2621046
Obstet Gynecol. 2011 Nov;118(5):1074-1080
pubmed: 22015875
Vaccine. 2016 Dec 20;34(52):6700-6706
pubmed: 27810314
Vaccine. 2014 Aug 6;32(36):4602-13
pubmed: 24996123
Med J Aust. 2013 Apr 15;198(7):373-5
pubmed: 23581957
J Matern Fetal Neonatal Med. 2012 Sep;25(9):1800-9
pubmed: 22339083
Am J Obstet Gynecol. 2011 Jul;205(1):10-8
pubmed: 21345415
Lancet Infect Dis. 2008 Jan;8(1):44-52
pubmed: 18156088
Obstet Gynecol. 2006 Jun;107(6):1315-22
pubmed: 16738158
Vaccine. 2019 Mar 28;37(14):1910-1917
pubmed: 30827735
BMJ. 2010 Mar 18;340:c1279
pubmed: 20299694
Vaccine. 2014 Apr 17;32(19):2150-9
pubmed: 24598724
Lung India. 2012 Jul;29(3):232-5
pubmed: 22919161
Vaccine. 2016 Oct 26;34(45):5400-5405
pubmed: 27646030
Vaccine. 2015 Sep 22;33(39):5103-9
pubmed: 26296492
Vaccine. 2018 May 31;36(23):3315-3322
pubmed: 29706294
Vaccine. 2016 Nov 21;34(48):5907-5911
pubmed: 27773474
Am J Obstet Gynecol. 2011 Feb;204(2):146.e1-7
pubmed: 20965490
MMWR Morb Mortal Wkly Rep. 2015 Sep 18;64(36):1000-5
pubmed: 26390253
Am J Obstet Gynecol. 2009 Dec;201(6):547-52
pubmed: 19850275
PLoS One. 2017 Jan 18;12(1):e0169221
pubmed: 28099486
Int J Gynaecol Obstet. 2014 Dec;127(3):234-7
pubmed: 25085688
Vaccine. 2015 Nov 25;33(47):6420-9
pubmed: 26320417
N Engl J Med. 2013 Jan 24;368(4):333-40
pubmed: 23323868
Am J Obstet Gynecol. 2012 Sep;207(3 Suppl):S3-8
pubmed: 22920056
Aust N Z J Obstet Gynaecol. 2018 Aug;58(4):417-424
pubmed: 29139107
Influenza Other Respir Viruses. 2016 Jul;10(4):254-67
pubmed: 26842617
N Engl J Med. 2008 Oct 9;359(15):1555-64
pubmed: 18799552
Am J Epidemiol. 1998 Dec 1;148(11):1094-102
pubmed: 9850132
Matern Child Health J. 2014 Jul;18(5):1205-14
pubmed: 24057990
PLoS One. 2017 Jan 26;12(1):e0170550
pubmed: 28125629
Vaccine. 2016 Jan 2;34(1):20-32
pubmed: 26602267